The high intensity focused ultrasound therapy market size is projected to reach US$ 924.07 million by 2031 from US$ 525.11 million in 2023. The market is expected to register a CAGR of 7.3% during 2023–2031. The growing applications of therapeutic ultrasound and significant research and development are likely to remain key trends in the market.

High Intensity Focused Ultrasound Therapy Market Analysis

The high intensity focused ultrasound market is driven by increasing awareness of early disease diagnosis and favorable regulatory scenarios for high-intensity focused ultrasound devices. Additionally, an increase in the elderly population and increased demand for high intensity focused ultrasound therapy are driving market growth. The increasing development of medical technology and its diverse applications in treating uterine fibroids, neurological diseases, aesthetic applications, and others have fueled the market's growth. Additionally, new applications such as gynecology and obstetrics, neurosurgery, urinary tract disease imaging, and removal of excess subcutaneous fat using high-energy sound waves would further drive the growth of the high-intensity focused ultrasound market in the next five years. However, stringent regulatory guidelines for approving innovative high intensity focused ultrasound technologies, increasing pricing pressure, and unfavorable reimbursement scenarios are the significant challenges market participants face, restraining the growth of this market.

High Intensity Focused Ultrasound Therapy Market Overview

High intensity focused ultrasound is a rapidly spreading therapeutic approach using ultrasound waves. Waves propagate through tissue media as energy carriers. High intensity focused ultrasound offers high potential for tumor ablation, hemostasis, thrombolysis, and targeted drug delivery. Cancer treatment is a critical issue in both developed and developed countries. The high frequency ultrasound waves used in therapy are also used to treat prostate cancer. It is widely used in interventional oncology due to its non-invasiveness, narrow treatment limits, and low complication rates. High intensity focused ultrasound systems have several advantages over traditional ultrasound systems, including shorter operative times and less bleeding. The high occurrence of cardiovascular disease (CVD) and cancer cases, the rapidly growing aging population, the increasing product launches, a growing number of clinical trials on the applications of high-intensity focused ultrasound, and the growing emphasis of key players on the technologically advanced systems are the key factors driving market growth. Additionally, surgical procedures using these devices are often less expensive, less intrusive, and less uncomfortable. The lack of skilled professionals and limitations associated with high intensity focused ultrasound as a technology inhibit high-intensity focused ultrasound market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

High Intensity Focused Ultrasound Therapy Market: Strategic Insights

High Intensity Focused Ultrasound Therapy Market

• 
  CAGR (2023 - 2031)

  7.3%
• Market Size 2023
  US$ 525.11 Million
• Market Size 2031
  US$ 924.07 Million

Market Dynamics

GROWTH DRIVERS

• Growing Prevalence of Cancer in World to Boost HIFU Usage
• Rising Incidences of Kidney Stone and Prostate Diseases
• Increasing Preference for Noninvasive Procedures

FUTURE TRENDS

• Side Effects Associated With HIFU Therapy

OPPORTUNITIES

• Growing Hospital Industry In Developing Countries Likely to Increase HIFU Comsumption

Key Players

• Koninklijke Philips N.V.,
• Image Guided Therapy (IGT),
• EDAP TMS,
• Sonacare Medical,
• Chongqing Haifu Medical Technology Co., Ltd.,
• Shanghai A & S Science Technology Development Co., Ltd,
• Mianyang Sonic Electronic,
• Insightec Ltd.,
• Alpinion Medical Systems Co., Ltd.,
• FUS Instruments

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Modality

• Therapeutic Ultrasound
• Hemostasis
• Others

Method

• Non-Invasive
• Minimal-Invasive

Application

• Uterine Fibroids
• Prostate Cancer
• Others

End User

• Hospitals
• Research Centers
• Diagnostic Centers

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

High Intensity Focused Ultrasound Therapy Market Drivers and Opportunities

Rising Incidences of Kidney Stone and Prostate Diseases to Favor Market

Urolithiasis or kidney stones lead to severe urinary tract infections with the formation of calcifications in the bladder and uterus. Owing to the increasing amount of lifestyle diseases, kidney stones have become a common cause. Around one in 1,000 people worldwide are affected, with the risk ratio for men and women being 3:1. According to a report by the Lancet Commission, the number of new prostate cancer cases each year is expected to rise from 1.4 million to 2.9 million in 2020 and 2040 respectively. An 85% increase in prostate cancer deaths per year would increase the total from 375,000 in 2020 to nearly 700,000 in 2040. Rising temperatures because of climate change will lead to a rise in kidney stone cases over the next seven decades, even if measures are taken to reduce greenhouse gas emissions, according to a new study by researchers at the Children's Hospital of Philadelphia (CHOP). Therefore, rising cases of prostate cancer and kidney stones are expected to drive market growth.

Growing Hospital Industry In Developing Countries

The growth of the hospital industry in developing countries is generating better opportunities for the key market players for expanding their business, which is likely to be a key enabler of the market growth during the forecast period. The Indian hospital sector expanded at a CAGR of 16–17% over 2017–2022. India also has a large pool of doctors and medical staff, which would potentially contribute to the growth of this industry to the higher level. Most of the major players in the high-intensity focused ultrasound therapy market focus on emerging countries such as India and China because of the presence of a large number of cancer patients and growing medical tourism in these countries. Many of the emerging countries are the preferred location for medical tourism. Thus, factors such as low cost and waiting time of treatment, and availability of advanced technologies is likely to provide growth opportunities for the high intensity focused ultrasound therapy market.

High Intensity Focused Ultrasound Therapy Market Report Segmentation Analysis

Key segments that contributed to the derivation of the high intensity focused ultrasound therapy market analysis are modality, method, application, and end user.

• Based on modality, the high intensity focused ultrasound therapy market is categorized into therapeutic ultrasound, hemostasis, and others. The therapeutic ultrasound segment held a largest market share in 2023.
• By method, the market is bifurcated into noninvasive and minimally invasive. The noninvasive segment held the larger share of the market in 2023 and is anticipated to register higher CAGR during 2021–2031.
• In terms of application, the market is segmented into uterine fibroids treatment, prostate cancer treatment, and others. The uterine fibroids treatment segment held a significant share of the market in 2023.
• Based on end user, the high intensity focused ultrasound therapy market is segmented into hospitals, research centers, and diagnostic centers. The hospital segment held a largest market share in 2023 and is projected to register the highest CAGR during the forecast period.

High Intensity Focused Ultrasound Therapy Market Share Analysis by Geography

The geographic scope of the high intensity focused ultrasound therapy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

The North America high intensity focused ultrasound market is characterized by the rising prevalence of cancer, uterine fibroids, and others, as well as the increasing awareness regarding the medical condition and the presence of supportive associations in the region. According to the American Society of Clinical Oncology, 1,414,259 people worldwide were diagnosed with prostate cancer as of February 2022. According to the National Kidney Foundation, ~10% of people in the US are expected to have kidney stone at some point in their lives. In addition, technological advancements of the noninvasive treatment of cancer are likely to be a major growth stimulator for the high-intensity focused ultrasound therapy market in North America.

High Intensity Focused Ultrasound Therapy Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

High Intensity Focused Ultrasound Therapy Market News and Recent Developments

The high intensity focused ultrasound therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the high intensity focused ultrasound therapy market are listed below:

• SONIRE Therapeutics Inc. announced that NHK WOLRD’s “Medical Frontiers” would focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program. (Source: SONIRE Therapeutics Inc., News, December 2023)
• Theraclion, an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, announced that it launched the first treatments for its FDA-approved pivotal study on the treatment of varicose veins using SONOVEIN in the US. (Theraclion, Press Release, October 2023)
• Theraclion, announced a phase-2 collaboration with the University of Virginia Cancer Center. This extends the investigation of combining HIFU with immunotherapy from late-stage to that of early-stage breast cancer. If successful, such a protocol could open a new way for treatment. (Source: Theraclion, Press Release, June 2021)

High Intensity Focused Ultrasound Therapy Market Report Coverage and Deliverables

The “High Intensity Focused Ultrasound Therapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• High intensity focused ultrasound therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• High intensity focused ultrasound therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• High intensity focused ultrasound therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the high intensity focused ultrasound therapy market
• Detailed company profiles